JP2013518867A5 - - Google Patents

Download PDF

Info

Publication number
JP2013518867A5
JP2013518867A5 JP2012551673A JP2012551673A JP2013518867A5 JP 2013518867 A5 JP2013518867 A5 JP 2013518867A5 JP 2012551673 A JP2012551673 A JP 2012551673A JP 2012551673 A JP2012551673 A JP 2012551673A JP 2013518867 A5 JP2013518867 A5 JP 2013518867A5
Authority
JP
Japan
Prior art keywords
salt
pharmaceutical composition
treatment
organic amine
salt according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012551673A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013518867A (ja
JP5852966B2 (ja
Filing date
Publication date
Priority claimed from TW099103071A external-priority patent/TWI504610B/zh
Priority claimed from GBGB1013511.9A external-priority patent/GB201013511D0/en
Application filed filed Critical
Priority claimed from PCT/GB2011/000133 external-priority patent/WO2011095768A1/en
Publication of JP2013518867A publication Critical patent/JP2013518867A/ja
Publication of JP2013518867A5 publication Critical patent/JP2013518867A5/ja
Application granted granted Critical
Publication of JP5852966B2 publication Critical patent/JP5852966B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012551673A 2010-02-02 2011-02-01 ランチビオティックの塩 Expired - Fee Related JP5852966B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
TW099103071A TWI504610B (zh) 2009-02-04 2010-02-02 阿肽加定衍生物、其製備方法及其用途
GC2010/15215 2010-02-02
PCT/GB2010/000188 WO2010089544A1 (en) 2009-02-04 2010-02-02 Actagardine derivatives
TW099103071 2010-02-02
GBPCT/GB2010/000188 2010-02-02
GCP201015215 2010-02-02
GB1013511.9 2010-08-11
GBGB1013511.9A GB201013511D0 (en) 2010-08-11 2010-08-11 Salts
PCT/GB2011/000133 WO2011095768A1 (en) 2010-02-02 2011-02-01 Lantibiotic salts

Publications (3)

Publication Number Publication Date
JP2013518867A JP2013518867A (ja) 2013-05-23
JP2013518867A5 true JP2013518867A5 (cg-RX-API-DMAC10.html) 2014-03-20
JP5852966B2 JP5852966B2 (ja) 2016-02-03

Family

ID=46759960

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012551673A Expired - Fee Related JP5852966B2 (ja) 2010-02-02 2011-02-01 ランチビオティックの塩

Country Status (7)

Country Link
US (1) US20120309676A1 (cg-RX-API-DMAC10.html)
EP (1) EP2531519A1 (cg-RX-API-DMAC10.html)
JP (1) JP5852966B2 (cg-RX-API-DMAC10.html)
CA (1) CA2789164A1 (cg-RX-API-DMAC10.html)
MX (1) MX2012008819A (cg-RX-API-DMAC10.html)
TW (1) TW201138800A (cg-RX-API-DMAC10.html)
WO (1) WO2011095768A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1013511A (en) 1963-01-31 1965-12-15 Decca Ltd Improvements in or relating to systems for steering an electric current to a selected
GB8507528D0 (en) * 1985-03-22 1985-05-01 Lepetit Spa Basis monocarboxyamide derivatives
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
EP1294358B1 (en) 2000-06-28 2004-08-18 Smithkline Beecham Plc Wet milling process
US7034113B2 (en) * 2002-02-22 2006-04-25 Paradigm Diagnostics, Llc Bacteriocin-metal complexes in the detection of pathogens and other biological analytes
GB0600928D0 (en) * 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
GB0714030D0 (en) * 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
GB0714029D0 (en) * 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
DE102008036269A1 (de) 2008-08-04 2010-02-11 Ewe Ag Vorrichtung zum kontinuierlichen Mischen von ausgespeichertem Erdgas mit Sauerstoff zu einem Brenngas für eine Erwärmung des unter Druck stehenden Erdgases vor oder nach seiner Entspannung
EA020733B1 (ru) * 2009-02-04 2015-01-30 Новакта Биосистемс Лимитед Производные актагардина

Similar Documents

Publication Publication Date Title
JP5756495B2 (ja) ペプチドおよびその使用
TWI391135B (zh) 抗菌劑的腸胃外製劑
TW201431866A (zh) 硼酸衍生物及其治療用途
JP5207734B2 (ja) 細菌感染症を治療するためのダルババンシン組成物
JP2016529325A (ja) 抗微生物化合物ならびにそれの製造方法および使用方法
TW201028161A (en) Novel antibacterial agents for the treatment of gram positive infections
JP2013509389A5 (cg-RX-API-DMAC10.html)
TWI335332B (en) Cross-linked vancomycin-cephalosporin antibiotics
JP6142076B2 (ja) 抗微生物性増強剤
JP2017218457A (ja) キサントン化合物の誘導体
TWI325323B (en) Cross-linked glycopeptide-cephalosporin antibiotics
ES2858431T3 (es) Purificación de pleuromutilina
TW201032817A (en) Compounds
CN102180890B (zh) 头孢硫脒结晶物及其用途
WO2020117755A1 (en) Compositions and methods for treating biofilms
JP2024009968A5 (cg-RX-API-DMAC10.html)
TW200848062A (en) Semi-synthetic glycopeptides with antibacterial activity
KR20170032348A (ko) 저 치환된 폴리믹신 및 이의 조성물
JP6590924B2 (ja) 微生物感染を治療するための相乗的組成物
JP2017514887A (ja) 抗菌性コンジュゲート、その製造方法及び使用
US20240261256A1 (en) Methods of treating bacterial infections
JP2017506240A (ja) 抗菌剤を含む医薬組成物
JP5357335B2 (ja) R−7−(3−アミノメチル−4−メトキシイミノ−3−メチル−ピロリジン−1−イル)−1−シクロプロピル−6−フルオロ−4−オキソ−1,4−ジヒドロ−[1,8]ナフチリジン−3−カルボキシル酸l−アスパラギン酸塩、その製造方法及びこれを含む抗菌用薬学的組成物
JP6441229B2 (ja) 抗菌化合物
JP6626516B2 (ja) 抗菌組成物及び方法